Hjem › Overvekt › North Carolina › Charlotte
Kliniske studier for Overvekt i Charlotte, NC
15 studier for Overvekt søker deltakere på steder i og rundt Charlotte (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruttererFase 3
- Novant Health Heart and Vascular Institute, Charlotte
- Monroe Biomedical Research, Monroe · 24 mi unna
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 2
- Monroe Biomedical Research /ID# 282009, Monroe · 24 mi unna
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RekruttererFase 3
- Monroe Biomedical Research, Monroe · 24 mi unna
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Monroe Biomedical Research, Monroe · 24 mi unna
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekruttererFase 3
- Monroe Biomedical Research, Monroe · 24 mi unna
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruttererFase 3
- Research Site, Monroe · 24 mi unna
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Charlotte
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 3
- AURORA-1 Clinical Site, Charlotte
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
- ACCOMPLISH-2 Research Site, Charlotte
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Monroe Biomedical Research, Monroe · 24 mi unna
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RekruttererFase 4
- Onsite Clinical Solutions - Huntersville, Huntersville · 13 mi unna
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RekruttererFase 3
- Kailera Clinical Site, Monroe · 24 mi unna
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RekruttererFase 3
- ACCOMPLISH-1 Research Site, Charlotte
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RekruttererFase 1
- Monroe Biomedical Research, LLC, Monroe · 24 mi unna
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
RekruttererFase 2
- Monroe Biomedical Research, Monroe · 24 mi unna
Overvekt-studier i andre byer
- San Antonio, TX34 studier
- Houston, TX33 studier
- Chicago, IL29 studier
- Orlando, FL27 studier
- Las Vegas, NV23 studier
- Miami, FL23 studier
- Dallas, TX20 studier
- Atlanta, GA20 studier
- New York City, NY19 studier
- Jacksonville, FL19 studier
- Washington, DC19 studier
- Austin, TX18 studier
Andre studier i Charlotte
- Kreft (alle typer)27 studier
- Brystkreft22 studier
- Multipelt myelom21 studier
- Ikke-småcellet lungekreft19 studier
- Akut myelogen leukemi16 studier
- Fedme16 studier
- Kolorektal kreft13 studier
- Eggstokkreft12 studier
- Hjertesvikt11 studier
- Metastatisk kreft11 studier
- Plateepitelcancer i hode og hals10 studier
- KOLS9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.